Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185

Ding, Yuntao; Wang, Huizhi; Liu, Junqiang; Jiang, Han; Gong, Aihua; Xu, Min

doi:10.3390/cancers15215120

Open AccessCorrection

Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185

by

Yuntao Ding

^1,†

,

Huizhi Wang

^1,†,

Junqiang Liu

¹,

Han Jiang

¹,

Aihua Gong

^2,* and

Min Xu

^1,*

¹

Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang 212000, China

²

Hematological Disease Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhenjiang 212001, China

^*

Authors to whom correspondence should be addressed.

^†

These authors contributed equally to this work.

Cancers 2023, 15(21), 5120; https://doi.org/10.3390/cancers15215120

Submission received: 6 September 2023 / Accepted: 9 October 2023 / Published: 24 October 2023

(This article belongs to the Section Cancer Biomarkers)

Download Versions Notes

In the published paper [1], there was an error regarding the affiliation for Huizhi Wang. Yuntao Ding and Huizhi Wang contributed equally to this work and share co-first authorship, as stated in the Author Contributions section. The updated affiliation should include: †—These authors contributed equally to this work. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

Ding, Y.; Wang, H.; Liu, J.; Jiang, H.; Gong, A.; Xu, M. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial-Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185. [Google Scholar] [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Ding, Y.; Wang, H.; Liu, J.; Jiang, H.; Gong, A.; Xu, M. Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185. Cancers 2023, 15, 5120. https://doi.org/10.3390/cancers15215120

AMA Style

Ding Y, Wang H, Liu J, Jiang H, Gong A, Xu M. Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185. Cancers. 2023; 15(21):5120. https://doi.org/10.3390/cancers15215120

Chicago/Turabian Style

Ding, Yuntao, Huizhi Wang, Junqiang Liu, Han Jiang, Aihua Gong, and Min Xu. 2023. "Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185" Cancers 15, no. 21: 5120. https://doi.org/10.3390/cancers15215120

APA Style

Ding, Y., Wang, H., Liu, J., Jiang, H., Gong, A., & Xu, M. (2023). Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185. Cancers, 15(21), 5120. https://doi.org/10.3390/cancers15215120

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

Correction: Ding et al. MBD3 as a Potential Biomarker for Colon Cancer: Implications for Epithelial–Mesenchymal Transition (EMT) Pathways. Cancers 2023, 15, 3185

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI